PLK1 is broadly involved in cancer development and is a potential target for clinical therapy.[79] We further analyzed the patients’ pathological stage in relation to the PIR value and found a negative correlation between PIR value and tumorigenicity (Figure 6J). Here, PLK1 is linked to cancer.